Figure 3From: Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisPercentage of symptomatic remitters* during the study. *Symptomatic remitters = participants who achieved ADHD-RS-IV total scores ≤ 18.Back to article page